Erythropoietin combined with granulocyte colony‑stimulating factor enhances MMP-2 expression in mesenchymal stem cells and promotes cell migration
- PMID: 21461559
- DOI: 10.3892/mmr.2010.387
Erythropoietin combined with granulocyte colony‑stimulating factor enhances MMP-2 expression in mesenchymal stem cells and promotes cell migration
Abstract
Mesenchymal stem cells (MSCs) are promising clinical tools, but the molecular mechanisms that regulate the mobilization and homing of MSCs and cause invasion through extracellular matrix (ECM) barriers are unknown. Matrix metalloproteinase (MMP) degrades the ECM and promotes cell migration. In this study, we investigated MMP expression and cell migration after treatment with erythropoietin (EPO) and granulocyte colony-stimulating factor (G-CSF). Specifically, we studied whether EPO combined with G-CSF enhanced MMP expression and increased the in vitro motility of MSCs. Real-time PCR was used to detect the mRNA of MMPs and tissue inhibitors of metalloproteinase. Cell migration was evaluated by transwell and wound healing assays. Western blotting was used to detect changes in ERK1/2 protein levels. The results showed that EPO combined with G-CSF enhanced MMP-2 expression in MSCs, promoted MSC motility and activated the ERK1/2 signaling pathway. Thus, a combination treatment of EPO with G-CSF promoted cell migration by stimulating MMP-2 expression in MSCs and this appeared to be related to the ERK1/2 signaling pathway.
Similar articles
-
[The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].Zhonghua Yi Xue Za Zhi. 2006 Nov 14;86(42):2966-70. Zhonghua Yi Xue Za Zhi. 2006. PMID: 17288807 Chinese.
-
H-Ras-specific upregulation of granulocyte colony-stimulating factor promotes human breast cell invasion via matrix metalloproteinase-2.Cytokine. 2011 Jul;55(1):126-33. doi: 10.1016/j.cyto.2011.03.002. Epub 2011 Apr 27. Cytokine. 2011. PMID: 21524920
-
Transduction of human EPO into human bone marrow mesenchymal stromal cells synergistically enhances cell-protective and migratory effects.Mol Biol (Mosk). 2010 Jul-Aug;44(4):656-63. Mol Biol (Mosk). 2010. PMID: 20873225
-
MT1-MMP association with membrane lipid rafts facilitates G-CSF--induced hematopoietic stem/progenitor cell mobilization.Exp Hematol. 2010 Sep;38(9):823-35. doi: 10.1016/j.exphem.2010.05.002. Epub 2010 May 13. Exp Hematol. 2010. PMID: 20471446
-
Granulocyte-colony-stimulating factor stimulation of bone marrow mesenchymal stromal cells promotes CD34+ cell migration via a matrix metalloproteinase-2-dependent mechanism.Stem Cells Dev. 2012 Nov 20;21(17):3162-72. doi: 10.1089/scd.2012.0048. Epub 2012 Jul 24. Stem Cells Dev. 2012. PMID: 22651889 Free PMC article.
Cited by
-
Lightwave-reinforced stem cells with enhanced wound healing efficacy.J Tissue Eng. 2021 Dec 18;12:20417314211067004. doi: 10.1177/20417314211067004. eCollection 2021 Jan-Dec. J Tissue Eng. 2021. PMID: 34987748 Free PMC article.
-
Shattering barriers toward clinically meaningful MSC therapies.Sci Adv. 2020 Jul 22;6(30):eaba6884. doi: 10.1126/sciadv.aba6884. eCollection 2020 Jul. Sci Adv. 2020. PMID: 32832666 Free PMC article. Review.
-
To Explore the Stem Cells Homing to GBM: The Rise to the Occasion.Biomedicines. 2022 Apr 24;10(5):986. doi: 10.3390/biomedicines10050986. Biomedicines. 2022. PMID: 35625723 Free PMC article. Review.
-
Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis.Biomed Res Int. 2013;2013:561098. doi: 10.1155/2013/561098. Epub 2013 Dec 5. Biomed Res Int. 2013. PMID: 24381939 Free PMC article. Review.
-
Modified mesenchymal stem cells in cancer therapy: A smart weapon requiring upgrades for wider clinical applications.World J Stem Cells. 2022 Jan 26;14(1):54-75. doi: 10.4252/wjsc.v14.i1.54. World J Stem Cells. 2022. PMID: 35126828 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
